Cargando…
Tau pathology-dependent remodelling of cerebral arteries precedes Alzheimer’s disease-related microvascular cerebral amyloid angiopathy
Alzheimer’s disease (AD) is characterised by pathologic cerebrovascular remodelling. Whether this occurs already before disease onset, as may be indicated by early Braak tau-related cerebral hypoperfusion and blood–brain barrier (BBB) impairment found in previous studies, remains unknown. Therefore,...
Autores principales: | Merlini, Mario, Wanner, Debora, Nitsch, Roger M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4835519/ https://www.ncbi.nlm.nih.gov/pubmed/26988843 http://dx.doi.org/10.1007/s00401-016-1560-2 |
Ejemplares similares
-
The Amyloid-Tau-Neuroinflammation Axis in the Context of Cerebral Amyloid Angiopathy
por: Cisternas, Pablo, et al.
Publicado: (2019) -
Tau as a mediator of neurotoxicity associated to cerebral amyloid angiopathy
por: You, Yingjian, et al.
Publicado: (2019) -
Cerebral amyloid angiopathy in the aetiology and immunotherapy of Alzheimer disease
por: Weller, Roy O, et al.
Publicado: (2009) -
Gait in Cerebral Amyloid Angiopathy
por: Sharma, Breni, et al.
Publicado: (2022) -
Cerebral amyloid angiopathy: an update
por: Schroeder, B. E., et al.
Publicado: (2023)